| Literature DB >> 30927607 |
H Helakari1, J Kananen2, N Huotari2, L Raitamaa2, T Tuovinen2, V Borchardt2, A Rasila2, V Raatikainen3, T Starck3, T Hautaniemi2, T Myllylä4, O Tervonen2, S Rytky5, T Keinänen3, V Korhonen2, V Kiviniemi2, H Ansakorpi6.
Abstract
OBJECTIVE: Epilepsy causes measurable irregularity over a range of brain signal frequencies, as well as autonomic nervous system functions that modulate heart and respiratory rate variability. Imaging dynamic neuronal signals utilizing simultaneously acquired ultra-fast 10 Hz magnetic resonance encephalography (MREG), direct current electroencephalography (DC-EEG), and near-infrared spectroscopy (NIRS) can provide a more comprehensive picture of human brain function. Spectral entropy (SE) is a nonlinear method to summarize signal power irregularity over measured frequencies. SE was used as a joint measure to study whether spectral signal irregularity over a range of brain signal frequencies based on synchronous multimodal brain signals could provide new insights in the neural underpinnings of epileptiform activity.Entities:
Keywords: EEG; Epilepsy; Irregularity; NIRS; Parasympathetic; Ultra-fast fMRI
Mesh:
Year: 2019 PMID: 30927607 PMCID: PMC6444290 DOI: 10.1016/j.nicl.2019.101763
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographics of patients with drug-resistant epilepsy (DRE).
| Patient | Gender | Age (years) | Duration of epilepsy (years) | Type of seizures | Etiology of epilepsy | AEDs | Number of scans | |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 32 | 8 | focal to impaired awareness | S? | CBZ 800 mg, PGB 300 mg | 2 | |
| 2 | F | 36 | 10 | focal to impaired awareness | S | LTG 550 mg, TPR 200 mg | 4 | |
| 3 | F | 26 | 19 | focal to bilateral tonic-clonic | U | LCM 200 mg, LTG 175 mg, | 2 | |
| VPA 1500 mg, CLB 10 mg | ||||||||
| 4 | F | 52 | 4 | focal to impaired awareness | U | LCM 150 mg, ZNS 100 mg | 4 | |
| 5 | M | 36 | 6 | focal to bilateral tonic-clonic | U | LEV 2500 mg, OXCB 1200 mg, | 4 | |
| LCM 300 mg | ||||||||
| 6 | M | 53 | 13 | focal to bilateral tonic-clonic | U | LTG 100 mg, LCM 200 mg, | 3 | |
| TPR 125 mg | ||||||||
| 7 | F | 22 | 12 | focal to bilateral tonic-clonic | U | VPA 900 mg, LTG 250 mg, | 4 | |
| CLB 10 mg | ||||||||
| 8 | F | 25 | 11 | focal to impaired awareness | U | OXCB 1200 mg, ZNS 400 mg | 4 | |
| 9 | F | 35 | 12 | focal to impaired awareness | U | TPR 100 mg, LCM 500 mg, | 4 | |
| CLB 30 mg | ||||||||
| 10 | F | 26 | 7 | focal to impaired awareness | U | LEV 2000 mg, LCM 150 mg, | 4 | |
| LTG 400 mg | ||||||||
AEDs, anti-epileptic drugs; S, structural; U, unknown; CBZ, Carbamazebine; PGB, Pregabalin; LTG, Lamotrigine; TPR, Topimarate; LCM, Lacosamide; VPA, Valproic acid; CLB, Clonazepam; ZNS, Zonisamide; LEV, Levetiracetam; OXCB, Oxcarbamazebine.
Fig. 1Scanning, preprocessing and analysis with multimodal setup. A) MREG, EEG and NIRS methods separated. B) Voxelwise MREG signal after preprocessing and FIX. Temporal signals (global MREG, EEG, 32 channels, NIRS (Hbo, Hb, HbT) used in analysis, 10-min measures of all and 2-min sliding window measures of global MREG and NIRS. C) PSD calculated from all signals. D) SE calculated by Shannon's equation separately from all signals on chosen sub-bands (0.009–0.08 Hz, 0.12–0.4 Hz, 0.7–1.6 Hz, 0.08–5 Hz, 0–5 Hz). As a result SE value for all voxels in MREG and for global MREG signal, for EEG (all 32 leads, visualized in map), and for NIRS (Hbo, Hb, HbT). 0 < SE value <1. In SEMREG: bright yellow = highest SE, dark red = lowest SE. In SEEEG: purple = highest SE, bright blue = lowest SE. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 2A) Average spectral entropy (SE) maps of FB MREG and FB MREG including FIX for DRE patients (n = 10) and HC (n = 10). Red illustrates the lowest and yellow the highest SEMREG values (cut off 0.5). B) SEMREG of FB MREG FIX was significantly higher in DRE patients than in HC in right thalamus, mid cingulate gyrus, inferior frontal gyrus, and frontal pole.
Group comparison of spatial SEMREG between DRE patients and HC.
| DRE > HC | Volume (μl) | Mean t-score | SEM | Max int. | MNI coordinates | ||
|---|---|---|---|---|---|---|---|
| X | Y | Z | |||||
| Right Thalamus | 608 | 3.9548 | 0.0312 | 4.7676 | 14 | −14 | 2 |
| Cingulate Gyrus, anterior division | 496 | 3.8828 | 0.0467 | 5.1316 | 4 | −2 | 38 |
| Inferior Frontal Gyrus, pars triangularis | 352 | 4.0919 | 0.041 | 4.6421 | 44 | 22 | 12 |
| Frontal pole, Left Cerebral Cortex | 136 | 4.2881 | 0.0375 | 4.6113 | −4 | 62 | −6 |
FB SEMREG was significantly (p < 0.05) higher in DRE (n = 10) than HC (n = 10) in several clusters. Volume, cluster size as voxels, Mean t-score, standard error of mean (SEM), maximum intensity (Max int.) and Max (X,Y;Z) as MNI coordinates are listed.
Fig. 3Group-differences between DRE patients and HC in different SE measures, presented for 0–5 Hz, FB. Orange and yellow indicate a significant group-difference at p < 0.05(*), and p < 0.01 (**), respectively. A) Static SEEEG for separate channels (mean ± STD) and spatial representation of EEG channels with indicators for increases in DRE patients. NIRS sensor indicated. B) SEMREG map indicating an increase in frontal pole (where also NIRS sensor placed) and cingulate gyrus in DRE patients. C) SENIRS group differences in HbO, Hb (significantly lower in DRE patients), and HbT.
Group comparison of 10-min SENIRS between DRE patients and HC, significant results.
| Band | SENIRS, Average ± Standard deviation | |||
|---|---|---|---|---|
| DRE patients | HC | * < 0.05 | ||
| 0–5 Hz | Hb | 0.40 ± 0.06 | 0.46 ± 0.10 | 0.045* |
| 0.08–5 Hz | Hb | 0.44 ± 0.13 | 0.58 ± 0.14 | 0.017* |
| 0.12–0.4 Hz | HbO | 0.85 ± 0.05 | 0.88 ± 0.02 | 0.038* |
| HbT | 0.85 ± 0.05 | 0.88 ± 0.03 | 0.045* | |
| 0.7–1.6 Hz | Hb | 0.39 ± 0.20 | 0.54 ± 0.24 | 0.038* |
HbO, oxygenated; Hb, deoxygenated; HbT, total hemoglobin.
List of significant differences between DRE patients and HC in dynamic 2-min sliding window SE calculated based on NIRS (HbO, Hb, HbT, 9 DRE patients and 10 HC) and global MREG signal (10 DRE patients and 10 HC).
| SENIRS | DRE patients | < | HC | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n = 9 | * < 0.05 | ** < 0.01 | ||||||||
| Time window [min] | 0–2 | 1–3 | 2–4 | 3–5 | 4–6 | 5–7 | 6–8 | 7–9 | 8–10 | |
| Band | ||||||||||
| 0–5 Hz | Hb* | |||||||||
| 0.009–0.08 Hz | Hb* | |||||||||
| 0.08–5 Hz | Hb*, HbT* | Hb* | Hb* | Hb* | Hb* | HbO* | ||||
| 0.12–0.4 Hz | HbT* | HbT* | HbO**, Hb*, HbT** | Hb* | HbT* | |||||
| 0.7–1.6 Hz | ||||||||||
| DRE patients n = 10 | HC n = 10 | |||||||||
| 0–5 Hz | DRE > HC* | |||||||||
| 0.009–0.08 Hz | DRE > HC* | DRE < HC* | ||||||||
| 0.08–5 Hz | ||||||||||
| 0.12–0.4 Hz | DRE > HC* | DRE > HC* | ||||||||
| 0.7–1.6 Hz | ||||||||||
HbO, oxygenated; Hb, deoxygenated; HbT, total hemoglobin. *: p < 0.05, **: p < 0.01.
Fig. 4Group-differences between DRE patients and HC in different SE measures presented for 0.12–0.4 Hz, RFP. Orange and yellow indicate a significant group-difference at p < 0.05(*), and p < 0.01 (**), respectively. A) Static SEEEG for separate channels (mean ± STD) and spatial representation of EEG channels with indicators for increases in DRE patients. B) Dynamic sliding-window results in SEMREG. C) Dynamic sliding-window results in SENIRS HbT.